Published in BMJ on February 08, 1997
Spectrum of clinical disease in a series of 135 hospitalised HIV-infected patients from north India. BMC Infect Dis (2004) 2.64
Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa. J Int AIDS Soc (2012) 2.02
HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health (2000) 1.74
Survival by AIDS defining condition in rural Uganda. Sex Transm Infect (2000) 1.02
Impact of housing on the survival of persons with AIDS. BMC Public Health (2009) 1.01
Can we predict the prognosis of HIV infection? How to use the findings of a prospective study. Sex Transm Infect (1998) 0.92
Managing Medicare's HIV caseload in the era of suppressive therapy. Am J Public Health (2007) 0.79
Survival of AIDS patients in Croatia prior to the introduction of combined antiretroviral therapy with protease inhibitors. Eur J Epidemiol (2000) 0.75
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
Meta-analysis: principles and procedures. BMJ (1997) 6.87
Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci (1973) 6.62
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem (2005) 4.94
Confounding in epidemiological studies: why "independent" effects may not be all they seem. BMJ (1992) 4.79
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet (2000) 4.67
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med (2000) 4.12
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology (1998) 4.01
Smoking as "independent" risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet (1992) 3.92
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax (2004) 3.77
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ (1989) 3.43
Growth, survival, and resistance of the Legionnaires' disease bacterium. Ann Intern Med (1979) 3.36
S-nitrosothiols signal the ventilatory response to hypoxia. Nature (2001) 3.26
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
T-cell receptor variable gene products and early HIV-1 infection. Lancet (1992) 3.20
Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17
Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet (1989) 3.15
Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Lancet (1995) 2.90
Passive smoking and health: should we believe Philip Morris's "experts"? BMJ (1996) 2.76
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood (2001) 2.57
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ (1989) 2.47
A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J Virol (1993) 2.46
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
Theophylline prescribing, serum concentrations, and toxicity. Lancet (1983) 2.40
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med (2006) 2.38
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med (1998) 2.38
Gastrointestinal manifestations of HIV infection. Lancet (1996) 2.38
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis (2004) 2.26
Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med (2008) 2.26
Inflation in epidemiology: "the proof and measurement of association between two things" revisited. BMJ (1996) 2.24
Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS (1996) 2.22
The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol (2000) 2.20
Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol (1993) 2.17
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy. J Infect Dis (2006) 2.09
Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol (1998) 2.08
Epidemiology of cerebral palsy in England and Scotland, 1984-9. Arch Dis Child Fetal Neonatal Ed (1998) 2.01
Cardio- and cerebrovascular events in HIV-infected persons. AIDS (2004) 1.98
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol (1997) 1.97
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group. Lancet (1999) 1.95
Migration and geographic variations in ischaemic heart disease in Great Britain. Lancet (1989) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells. AIDS (1994) 1.93
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis (1997) 1.90
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J (1990) 1.89
Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. BMJ (1994) 1.87
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS (2001) 1.86
Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med (1996) 1.82
Tenofovir-associated renal and bone toxicity. HIV Med (2009) 1.82
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med (1997) 1.80
Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? Sex Transm Infect (2004) 1.79
Impact of HIV infection on mortality in young men in a London health authority. BMJ (1992) 1.78
HHV-6 in AIDS. Lancet (1994) 1.76
ABO blood group and ischaemic heart disease in British men. BMJ (1990) 1.76
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med (2006) 1.73
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 1.73
Infrared signature of structures associated with the H+(H2O)n (n = 6 to 27) clusters. Science (2004) 1.71
Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet (1999) 1.69
Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A (1988) 1.69
Biochemistry of Oleoresinosis : Monoterpene and Diterpene Biosynthesis in Lodgepole Pine Saplings Infected with Ceratocystis clavigera or Treated with Carbohydrate Elicitors. Plant Physiol (1987) 1.68
Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS (1997) 1.68
A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet (1997) 1.68
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis (1998) 1.67
Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr (2000) 1.67
Frequency of inherited bleeding disorders in women with menorrhagia. Lancet (1998) 1.66
Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. J Infect Dis (2000) 1.66
Further observations on the pathological responses of rat skeletal muscle to toxins isolated from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin Exp Pharmacol Physiol (1979) 1.66
Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. AIDS (1999) 1.65